NuMind Health is a groundbreaking mental health organization dedicated to revolutionizing treatment through Government approved, innovative, plant-based therapies. Our business model centres around providing comprehensive care for individuals struggling with addiction, PTSD, and other mental health disorders.
Customers: Our target demographic includes individuals seeking alternative, effective solutions for mental health challenges, as well as healthcare professionals and organizations looking to partner with leaders in psychedelic-assisted therapy.
Products: We offer licensed psychedelic-assisted therapy using substances like Ibogaine for addiction and MDMA for PTSD. Additionally, we provide experiential training for therapists, aftercare retreats, and wellness programs focusing on holistic healing.
Team: Our team comprises experienced healthcare professionals, therapists, researchers, and thought leaders in the field of psychedelic medicine. Led by CEO Richard Avis, our diverse team brings a wealth of expertise and passion to our mission.
Credentials: NuMind Health boasts partnerships with renowned experts such as Dr. Rick Doblin of MAPS and Mr. John Giordano, a pioneer in addiction treatment. We have received formal government approvals for our treatments and maintain strict adherence to ethical and legal standards.
Innovation: We are committed to pushing the boundaries of traditional mental health treatment, leveraging cutting-edge research and technology to provide personalized, effective care. Our focus on holistic healing and individualized treatment plans sets us apart in the industry.
Impact: Through our transformative therapies and compassionate approach, we aim to empower individuals to reclaim their lives and achieve lasting recovery. By addressing the root causes of mental illness, we strive to make a meaningful difference in the lives of our clients and communities worldwide.
Ready to Ask For Funding for your company?
Post a Funding Request